Various molecular markers, including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), and Ki67, are widely used in the prognosis of breast cancer and to make treatment-related decisions (Untch et al., 2019). This evidence concerns the gene PGR and breast cancer.